Subscribe free

Metabolic and Bariatric Surgery ·

Effectiveness and Safety of Metabolic and Bariatric Surgery in Patients with Chronic Kidney Disease

Metabolic and bariatric surgery (MBS) is effective for sustained weight loss in chronic kidney disease (CKD) patients, with acceptable complication rates. Roux-en-Y gastric bypass (RYGB) leads to higher weight loss percentages but carries a higher risk of late surgical complications compared to sleeve gastrectomy (SG). CKD patients undergoing MBS saw improvements in kidney function, with some even receiving successful renal transplants. Future studies are needed to further evaluate the safety of MBS in this patient population.

Journal Article by Abi Mosleh K, Sample JW (…) Ghanem OM et 6 al. in Surg Endosc

© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

read the whole article in Surg Endosc

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Metabolic and Bariatric Surgery.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in Metabolic and Bariatric Surgery

The latest stitches

Surg Endosc29 Sep 2026

Endoscopic Sleeve Gastroplasty Offers Safer Alternative to LSG

Endoscopic sleeve gastroplasty (ESG) provides moderate weight loss with a lower risk of complications compared to laparoscopic sleeve gastrectomy (LSG), making it a viable option for patients, particularly those with existing gastro-esophageal reflux disease (GERD).

All papers in Metabolic and Bariatric Surgery →